reconstitution bpc 157 BPC-157 and Dosing BPC-157 Reconstitution & Storage: Lab

Contact us today to schedule a consultation or learn more about this procedure

TB-500 protocol considerations Reported dosing in the research literature: Starting dose: 500 mcg daily, subcutaneous injection Titration: Increase by 100 to 150 mcg every two weeks as tolerated Target dose: 750 to 1000 mcg daily by weeks five through twelve Weekly total: Approximately 5 mg per week at full dose Cycle length: Eight to twelve weeks, with optional extension to sixteen weeks TB-500 is typically administered once daily via subcutaneous injection, with consistent timing and systematic site rotation

It does not slot neatly into an endocrine signaling cascade

A similar finding (i.e., rehabilitation of skin wound and maturation of granulation tissue markedly promoted by BPC 157) was obtained in small-type pigs (Xue et al., 2004a)